跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,298 条关于
“Hubei JXBio Pharmaceutical”
全部
13,298
临床试验
541
药物
1,691
机构
2,177
资讯
8,889
上个月
Kazakhstan Registers Promomed's Tirzetta as First Officially Available Tirzepatide Drug in the Country
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
6年前
NIH Initiates Clinical Trial of Remdesivir for COVID-19 in the U.S.
去年
Pharmaceutical R&D Highlights: Key Clinical Updates from November 2024
去年
Lilly Expands Obesity Treatment Pipeline Through KeyBioscience Collaboration
去年
FDA Approves Bimzelx (bimekizumab-bkzx) for Moderate-to-Severe Hidradenitis Suppurativa
去年
SPIMA Therapeutics Launches with Focus on Peptide-Based Immunotherapies for Unmet Needs
去年
RAPT Therapeutics Licenses Novel Anti-IgE Antibody RPT904 for Global Development
去年
Merck & Co. to Acquire WuXi Biologics' Vaccine Facility in Ireland for $500 Million
去年
Shandong Xinhua Pharmaceutical Receives Approval for Pentazocine
第 1 页，共 889 页
上一页
下一页
